AURA
Price
$6.15
Change
+$0.27 (+4.59%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
365.26M
41 days until earnings call
HUMA
Price
$1.73
Change
+$0.12 (+7.45%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
255.72M
42 days until earnings call
Interact to see
Advertisement

AURA vs HUMA

Header iconAURA vs HUMA Comparison
Open Charts AURA vs HUMABanner chart's image
Aura Biosciences
Price$6.15
Change+$0.27 (+4.59%)
Volume$3.42K
Capitalization365.26M
Humacyte
Price$1.73
Change+$0.12 (+7.45%)
Volume$38.28K
Capitalization255.72M
AURA vs HUMA Comparison Chart in %
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HUMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. HUMA commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Buy and HUMA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (AURA: $5.88 vs. HUMA: $1.61)
Brand notoriety: AURA and HUMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 64% vs. HUMA: 39%
Market capitalization -- AURA: $365.26M vs. HUMA: $255.72M
AURA [@Biotechnology] is valued at $365.26M. HUMA’s [@Biotechnology] market capitalization is $255.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 1 FA rating(s) are green whileHUMA’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 1 green, 4 red.
  • HUMA’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than HUMA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 3 TA indicator(s) are bullish while HUMA’s TA Score has 4 bullish TA indicator(s).

  • AURA’s TA Score: 3 bullish, 5 bearish.
  • HUMA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, HUMA is a better buy in the short-term than AURA.

Price Growth

AURA (@Biotechnology) experienced а -6.07% price change this week, while HUMA (@Biotechnology) price change was -10.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +9.50%, and the average quarterly price growth was +52.01%.

Reported Earning Dates

AURA is expected to report earnings on Nov 06, 2025.

HUMA is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($365M) has a higher market cap than HUMA($256M). AURA YTD gains are higher at: -28.467 vs. HUMA (-68.119). HUMA has higher annual earnings (EBITDA): -40.86M vs. AURA (-107.51M). AURA has more cash in the bank: 177M vs. HUMA (38M). HUMA has less debt than AURA: HUMA (15.1M) vs AURA (18.1M). HUMA has higher revenues than AURA: HUMA (818K) vs AURA (0).
AURAHUMAAURA / HUMA
Capitalization365M256M143%
EBITDA-107.51M-40.86M263%
Gain YTD-28.467-68.11942%
P/E RatioN/AN/A-
Revenue0818K-
Total Cash177M38M466%
Total Debt18.1M15.1M120%
TECHNICAL ANALYSIS
Technical Analysis
AURAHUMA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HUMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALBKY0.910.03
+3.41%
Alpha Services and Holdings SA
CWLPF0.49N/A
N/A
Caldwell Partners International Inc.
MLLCF3.50N/A
N/A
Molecular Partners AG
TPRKY7.75N/A
N/A
Travis Perkins Plc
PIAIF6.50-0.65
-9.09%
Ping An Insurance (Group) Company of China Ltd.